Procter & Gamble Health Q3 Results
- BSE: 500126
- NSE: PGHL
- ISIN: INE199A01012
- Sector: Biotechnology & Drugs
BSE
5,227.05
-60.55 (-1.15%)
-60.55 (-1.15%)Volume178.00
Updated: Fri 11 Oct, 2024 | 15:28:00
NSE
5,234.95-67.10 (-1.27%)
-67.10 (-1.27%)Volume2.91 K
Updated: Fri 11 Oct, 2024 | 15:57:23
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Procter & Gamble Health Q3 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 22 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 252.48 | 309.97 | -% | 320.92 | -% |
| Selling/ General/ Admin Expenses Total | 48.46 | 47.26 | -% | 60.73 | -% |
| Depreciation/ Amortization | 6.84 | 8.23 | -% | 5.89 | -% |
| Other Operating Expenses Total | 62.72 | 70.91 | -% | 82.60 | -% |
| Total Operating Expense | 191.88 | 209.34 | -% | 247.15 | -% |
| Operating Income | 60.60 | 100.63 | -% | 73.77 | -% |
| Net Income Before Taxes | 62.72 | 104.94 | -% | 78.53 | -% |
| Net Income | 46.56 | 76.80 | -% | 59.19 | -% |
| Diluted Normalized EPS | 28.00 | 46.97 | -% | 34.73 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Israel-Iran war: Mazagon Dock, HAL to BEL — experts recommend these eight defence stocks to buy on Monday — Oct 14
3 min read01:50 PM IST - Markets
02Gold and silver prices today on 13-10-2024: Check latest rates in your city
2 min read10:15 AM IST - Markets
03Reliance share price: Should you buy RIL shares ahead of Q2 results 2024 on Monday?
2 min read11:17 AM IST